necitumumab Injection [Portrazza]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background Biologics have gained traction for use in oncology, but have demonstrate clinical variability for efficacy and safety…
Eli Lilly is developing necitumumab (Portrazza™), an intravenously administered fully human IgG monoclonal antibody directed…